| Dow | 15083.77 | -34.72 | (-0.23%) |
| Nasdaq | 3438.61 | +2.03 | (0.06%) |
| SP 500 | 1633.57 | -0.13 | (-0.00%) |
| 10-yr Note | -6/32 | 1.923 | |
| NYSE | Adv 1174 | Dec 1801 | Vol 268.2 mln |
| Nasdaq | Adv 1107 | Dec 1326 | Vol 935.2 mln |
| Strong: Consumer Staples, Health Care |
| Weak: Materials, Utilities, Industrials |
![]() |
March business inventories: 0.0% actual, +0.3% Briefing.com consensus, +0.1% prior April retail sales: +0.1% actual, -0.3% Briefing.com consensus, -0.5% prior Retail sales ex-auto: -0.1% actual, -0.2% Briefing.com consensus, -0.4% prior |
Only three sectors (consumer staples, financials, health care) trade in positive territory as all three register gains between 0.4% and 0.7%. The health care sector is the top performer as biotech continues its recent run. The iShares Nasdaq Biotechnology ETF (IBB 182.79, +2.77) is higher by 1.5% today, and up 6.3% this month. Biotechnology has been among the top performers of the year as the ETF trades with a year-to-date gain of 33.5%.
On the downside, the materials sector is lower by 0.7%. Miners are among the notable decliners as the Market Vectors Gold Miners ETF (GDX 29.18, -0.63) trades with a loss of 2.1% even as gold futures show little change.







